User: Guest

OVERACTIVE BLADDER (OAB) THERAPEUTICS

Global Market Trajectory & Analytics

MCP-6499

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

3014
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

543
Interactions with Platform & by Email

PARTICIPANTS

92
Unique # Participated

VALIDATIONS

41
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

108

PAGES

172

EDITION

19

PRICE

USD $5450


Amid the COVID-19 crisis, the global market for Overactive Bladder (OAB) Therapeutics estimated at US$3.2 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at aCAGR of 0.9% over the period 2020-2027. Anticholinergic Agents, one of the segments analyzed in the report, is projected to record 0.7% CAGR and reach US$2.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Beta-3 Adrenoreceptor Agonists segment is readjusted to a revised 1.4% CAGR for the next 7-year period.
The Overactive Bladder (OAB) Therapeutics market in the U.S. is estimated at US$865.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$621.7 Million by the year 2027 trailing a CAGR of 2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -0.2% and 0.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 0.1% CAGR.We bring years of research experience to this 19th edition of our report. The 172-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Allergan PLC; Astellas Pharma, Inc.; Dr. Reddy's Laboratories Ltd.; Eli Lilly and Company; Endo Pharmaceuticals, Inc.; Hisamitsu Pharmaceutical Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Recordati SpA; Speciality European Pharma Ltd.; Sunovion Pharmaceuticals, Inc.
» Drug Class (Anticholinergic Agents, and Beta-3 Adrenoreceptor Agonists)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
Overactive Bladder (OAB) Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Overactive Bladder (OAB) Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Overactive Bladder (OAB) Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Overactive Bladder (OAB) Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Anticholinergic Agents (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
Anticholinergic Agents (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Anticholinergic Agents (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Beta-3 Adrenoreceptor Agonists (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Beta-3 Adrenoreceptor Agonists (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Beta-3 Adrenoreceptor Agonists (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Overactive Bladder (OAB) Therapeutics Market Share (in %) by Company: 2019 & 2025
United States Overactive Bladder (OAB) Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
Overactive Bladder (OAB) Therapeutics Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
United States Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Canada
Canadian Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
Canadian Overactive Bladder (OAB) Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017
Overactive Bladder (OAB) Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
Japan
Japanese Market for Overactive Bladder (OAB) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
Japanese Overactive Bladder (OAB) Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
China
Chinese Overactive Bladder (OAB) Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
Chinese Overactive Bladder (OAB) Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Europe
Market Facts & Figures
European Overactive Bladder (OAB) Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Overactive Bladder (OAB) Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Overactive Bladder (OAB) Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
European Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
France
Overactive Bladder (OAB) Therapeutics Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
French Overactive Bladder (OAB) Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
French Overactive Bladder (OAB) Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
Germany
Overactive Bladder (OAB) Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
German Overactive Bladder (OAB) Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
German Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Italy
Italian Overactive Bladder (OAB) Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
Italian Overactive Bladder (OAB) Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Kingdom
United Kingdom Market for Overactive Bladder (OAB) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
United Kingdom Overactive Bladder (OAB) Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
Spain
Spanish Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
Spanish Overactive Bladder (OAB) Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017
Overactive Bladder (OAB) Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
Russia
Russian Overactive Bladder (OAB) Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
Overactive Bladder (OAB) Therapeutics Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
Russian Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
Rest of Europe Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Asia-Pacific
Asia-Pacific Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
Asia-Pacific Overactive Bladder (OAB) Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Overactive Bladder (OAB) Therapeutics Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Overactive Bladder (OAB) Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
Asia-Pacific Overactive Bladder (OAB) Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
Australia
Overactive Bladder (OAB) Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
Australian Overactive Bladder (OAB) Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
Australian Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
India
Indian Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
Indian Overactive Bladder (OAB) Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017
Overactive Bladder (OAB) Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
South Korea
Overactive Bladder (OAB) Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
South Korean Overactive Bladder (OAB) Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
Overactive Bladder (OAB) Therapeutics Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
Rest of Asia-Pacific
Rest of Asia-Pacific Market for Overactive Bladder (OAB) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
Rest of Asia-Pacific Overactive Bladder (OAB) Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
Latin America
Latin American Overactive Bladder (OAB) Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
Latin American Overactive Bladder (OAB) Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Latin American Overactive Bladder (OAB) Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
Latin American Overactive Bladder (OAB) Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Argentina
Argentinean Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
Argentinean Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Brazil
Overactive Bladder (OAB) Therapeutics Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
Brazilian Overactive Bladder (OAB) Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
Brazilian Overactive Bladder (OAB) Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
Mexico
Overactive Bladder (OAB) Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
Mexican Overactive Bladder (OAB) Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
Mexican Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Rest of Latin America
Rest of Latin America Overactive Bladder (OAB) Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
Overactive Bladder (OAB) Therapeutics Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
Rest of Latin America Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Middle East
The Middle East Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
The Middle East Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
The Middle East Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
The Middle East Overactive Bladder (OAB) Therapeutics Historic Market by Drug Class in US$ Million: 2009-2017
Overactive Bladder (OAB) Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
Iran
Iranian Market for Overactive Bladder (OAB) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
Iranian Overactive Bladder (OAB) Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
Israel
Israeli Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Overactive Bladder (OAB) Therapeutics Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
Israeli Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Saudi Arabia
Saudi Arabian Overactive Bladder (OAB) Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
Overactive Bladder (OAB) Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
Saudi Arabian Overactive Bladder (OAB) Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Arab Emirates
Overactive Bladder (OAB) Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
United Arab Emirates Overactive Bladder (OAB) Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
Overactive Bladder (OAB) Therapeutics Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
Rest of Middle East
Overactive Bladder (OAB) Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
Rest of Middle East Overactive Bladder (OAB) Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
Rest of Middle East Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Africa
African Overactive Bladder (OAB) Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
Overactive Bladder (OAB) Therapeutics Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
African Overactive Bladder (OAB) Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
Total Companies Profiled : 8

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com